(Photo: ANGELA WEISS/AFP via Getty Images)
(CNN) ––
Vaccine advisers at the US Centers for Disease Control and Prevention (CDC) voted 13-0 on Friday to support Moderna's vaccine recommendation against the two-dose covid-19, which received full approval from the Food and Drug Administration (FDA) earlier this week for use in adults.
The recommendation they voted for was: "The Moderna COVID-19 BLA (Spikevax, 2-dose primary series) approved vaccine is recommended for persons 18 years of age and older."
Before it was approved by the FDA, the vaccine was available under emergency use authorization and had previously been recommended on a provisional basis.
The CDC's Advisory Committee on Immunization Practices endorsed the vaccine after hearing details about Moderna's FDA application and the latest safety data.
There are no new safety concerns surrounding the Moderna vaccine in adults, but it has been linked to rare cases of two types of serious adverse events: anaphylaxis and myocarditis, a type of inflammation of the heart.
The overall risk of myocarditis is low, but the risk was higher among adolescent and young adult males after the second dose, the advisers heard.
News in development...
advertising
Vaccine